Haizhen Yang
- Immunology top 10%
- Rheumatology top 5%
- Molecular Biology
- Pathology and Forensic Medicine
- Dermatology top 10%
- Topics
- Systemic Lupus Erythematosus Research (5 papers)Atherosclerosis and Cardiovascular Diseases (4 papers)Obstructive Sleep Apnea Research (3 papers)
- Cited by
- RheumatologyImmunologyNephrology
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Haizhen Yang
23 papers receiving 463 citations
Peers
Comparison fields: 5 of 71
- Immunology 221
- Rheumatology 182
- Molecular Biology 102
- Pathology and Forensic Medicine 84
- Dermatology 58
Countries citing papers authored by Haizhen Yang
This map shows the geographic impact of Haizhen Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haizhen Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haizhen Yang more than expected).
Fields of papers citing papers by Haizhen Yang
This network shows the impact of papers produced by Haizhen Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haizhen Yang. The network helps show where Haizhen Yang may publish in the future.
Co-authorship network of co-authors of Haizhen Yang
This figure shows the co-authorship network connecting the top 25 collaborators of Haizhen Yang. A scholar is included among the top collaborators of Haizhen Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haizhen Yang. Haizhen Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 10 | |
| 3 | 3 | |
| 4 | 7 | |
| 5 | 11 | |
| 6 | 3 | |
| 7 | 13 | |
| 8 | 0 | |
| 9 | 2 | |
| 10 | 30 | |
| 11 | 27 | |
| 12 | 3 | |
| 13 | Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis: a randomized, double-blind, placebo-controlled multicenter trial. | 63 |
| 14 | 6 | |
| 15 | 68 | |
| 16 | 30 | |
| 17 | 19 | |
| 18 | 47 | |
| 19 | 67 | |
| 20 | A Nonsense Mutation in Transglutaminase1Gene and Loss of Enzyme Activity in a Family with Lamellar Ichthyosis | 1 |
About Haizhen Yang
Haizhen Yang is a scholar working on Nephrology, Rheumatology and Metals and Alloys, having authored 25 papers that have together received 475 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (5 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Obstructive Sleep Apnea Research (3 papers). The work is most often cited by research in Rheumatology (182 citations), Immunology (221 citations) and Nephrology (54 citations). Haizhen Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hong Zhang, Shu‐Feng Zhou, Ke Hu, Ying Tan, Yue Fang, Jicheng Lv, Feng Yu, Minghui Zhao, Swapan K. Nath and Ming‐Hui Zhao. Their work appears in journals such as Cancer Research, Scientific Reports and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.